Applications of Triclocarban in Industrial Manufacturing

Triclocarban serves as an antimicrobial active widely used by manufacturers in controlled and regulated industrial sectors. Our production expertise supports key applications requiring stringent compliance, precise integration, and consistent performance in finished products across major downstream markets.

1. Personal Care Antimicrobial Bar Soaps

Leading hygiene brands incorporate this material into bar soap formulations for its broad-spectrum antibacterial properties, targeting bacteria commonly encountered on skin surfaces. Manufacturers balance microbial reduction demands with safety guidelines, using processing methods to achieve uniform dispersion and product stability. Automated batching and quality control systems ensure each batch meets required antimicrobial activity levels, supporting mass production of branded personal wash bars for consumer and institutional sanitation programs.

Industry compliance standards

• ISO 22716 Cosmetics GMP
• US FDA Over-The-Counter Drug Monograph, 21 CFR 333.410 (banned for consumer hand soaps, allowed in specific non-prescription health settings)
• EU Cosmetics Regulation No. 1223/2009, Annex V and updates (use restrictions & prohibitions by country)
• China NMPA Technical Specifications for the Hygiene Supervision of Cosmetics

Typical usage ratio

• 0.2% to 1.5% by weight of total soap mass; formulation level adjusted based on regional limits, targeted antimicrobial performance, and soap base compatibility.

Downstream process integration

• Introduce after saponification, before final cooling and molding.
• Mix under controlled temperature to prevent additive degradation.
• Screen for homogeneity using sample testing before packaging.

Final product types

• Antibacterial hand bars for healthcare use
• Household deodorant soap bars
• Heavy-duty sanitation soap bars for industrial/food processing personnel
• Institutional wash blocks for high-traffic public facilities

2. Antimicrobial Cleaning Wipes and Surface Sanitizers

Industrial and commercial suppliers utilize this active in the manufacture of wet wipes and surface cleansing pads aimed at healthcare, food service, and hospitality markets. Integration into liquid and semi-solid wipe substrates requires careful solubilization and dispersion to achieve specified bioload reduction. Each batch undergoes validation per user application—for example, high-frequency touchpoint disinfection in public or occupational settings. Compliance controls address product performance and residue safety during use.

Industry compliance standards

• US EPA Product Registration for Antimicrobial Pesticides (when marketed as a sanitizer/disinfectant for surfaces)
• EN 16615 for wipe disinfection efficacy in the EU
• ISO 9001:2015 QMS with documented process validation
• Local authorities’ environmental safety and transport compliance regulations

Typical usage ratio

• 0.1% to 0.8% (w/w) based on substrate absorbance, solution concentration, and intended contact time as required by efficacy claims.

Downstream process integration

• Blend into aqueous or emulsion cleaning solutions in bulk mixing tanks, ensuring full dissolution.
• Impregnate into wipe substrates using automated coating or soaking lines before packaging.
• In-line QC testing for biocidal activity and extractable content prior to shipment.

Final product types

• Pre-moistened healthcare disinfectant wipes
• Industrial work surface cleaning pads
• Food service and hospitality degreasing wipes (for non-food surfaces)
• Antimicrobial screen and electronic device wipes

3. Medical Device Antimicrobial Coatings

Medical device manufacturers apply the ingredient in antimicrobial coatings for devices and utensils intended for clinical, laboratory, or surgical environments. Its inclusion targets prevention of biofilm formation and device contamination during routine use. Application technologies—such as solvent-based sprays, dip-coating, or direct blending into polymer matrices—require precision to meet medical regulatory thresholds for extractables and leachables. Regulatory submissions must include evidence for safety, effectiveness, and process reproducibility under actual use conditions as specified per lot.

Industry compliance standards

• ISO 10993-1 for biocompatibility assessment of medical devices
• Medical Device Directive 93/42/EEC or MDR 2017/745 in EU markets
• US FDA 21 CFR 820 Quality System Regulation
• USP Class VI Biological Reactivity Tests (for certain device categories)

Typical usage ratio

• 0.05% to 0.5% by weight in coating or polymer; exact ratio determined by device type, required duration of antimicrobial protection, and biocompatibility data.

Downstream process integration

• Add to coating solution or polymer feedstock prior to device fabrication.
• Post-coating curing or sterilization steps to activate and lock in antimicrobial properties.
• Documented in-process testing for uniformity and regulatory conformity.

Final product types

• Reusable clinical instrument handles
• Wound dressing carriers
• Implantable device housings (with regulatory caveats and limitations by region)
• Lab test trays and sample collection tools

4. Antimicrobial Textiles for Medical and Institutional Use

Professional textile processors use the compound in finishing treatments for hospital linens, uniforms, and hygiene textiles. Its role is to inhibit bacterial growth on fabrics subject to repeated contact with skin or bodily fluids. Companies apply it using padding, exhaustion, or spray techniques during the final finishing stage, subject to thorough rinsing protocols. Quality control evaluates residual antimicrobial content and wash durability, supporting claims regarding lasting protection through repeated laundering cycles in institutional environments.

Industry compliance standards

• Oeko-Tex Standard 100 (chemical safety for textiles)
• AATCC TM100 Antimicrobial Fabric Testing
• REACH Registration, Evaluation, and Authorization (as applicable for biocidal substances)
• ISO 18184:2019 for antiviral textile testing (if applicable in product development)

Typical usage ratio

• 0.1% to 0.7% by weight, finalized based on fabric composition, end-use requirements, and regional biocide regulations for treated articles.

Downstream process integration

• Apply treatment during final fabric finishing or as a post-weave bath.
• Cure and dry fabric at controlled temperatures to bind active to textile fibers.
• Sample runs tested for antimicrobial persistence and wash resistance.

Final product types

• Medical bed sheets and pillowcases
• Antimicrobial patient gowns
• Staff uniforms in healthcare and laboratory settings
• Protective drapes and wound dressing backings